The study of the psoriasin protein is still in an early stage2; however, its presence in urine suggests that it is a noninvasive marker capable of identifying cases of cancer and, according to Skliris et al.3, by being regulated by the activity of the estrogen receptor, this gene may represent a guide for target therapy. This evidence concerns the gene S100A7 and cancer.